Latest On Protagonist Therapeutics, Inc (PTGX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-26 01:04 EST | News | Protagonist Therapeutics Sees Steady If Bumpy Progress | N/A |  |
| 2023-05-24 20:54 EST | News | Protagonist Therapeutics: All Quiet Heading Into An Important H2 2023 | N/A | |
| 2023-05-12 13:28 EST | News | Protagonist Therapeutics and Janssen's collaboration shows promise for oral therapy for IL-23-mediated diseases | N/A | |
| 2023-05-05 17:50 EST | News | Protagonist GAAP EPS of -$0.67 in-line | N/A | |
| 2023-04-05 11:14 EST | News | Protagonist Therapeutics prices $100M offering | N/A | |
| 2023-04-04 19:17 EST | News | Protagonist falls on $100M public offering | N/A | |
| 2023-03-16 06:46 EST | News | Protagonist GAAP EPS of -$0.69 misses by $0.10 | N/A | |
| 2023-03-09 21:16 EST | News | Protagonist Therapeutics: More Good News Likely To Come | N/A | |
| 2023-03-07 23:28 EST | News | Johnson & Johnson, Protagonist succeed in mid-stage trial for psoriasis candidate | N/A | |
| 2023-03-07 08:43 EST | News | CDTX, PTGX and TAST among premarket gainers | N/A | |
| 2022-11-08 17:47 EST | News | Protagonist GAAP EPS of -$0.64 beats by $0.23 | N/A | |
| 2022-08-05 06:50 EST | News | Protagonist GAAP EPS of -$0.84 beats by $0.10 | N/A | |
| 2022-06-15 13:34 EST | News | Protagonist Therapeutics (PTGX) Presents At Jefferies Healthcare Conference - Slideshow | N/A | |
| 2022-06-08 23:40 EST | News | Protagonist: Too Many Red Flags | N/A | |
| 2022-06-01 03:40 EST | News | Protagonist Therapeutics (PTGX) Presents at Digestive Disease Week (DDW) 2022 | N/A | |
| 2022-05-05 08:14 EST | News | Protagonist GAAP EPS of -$0.43 beats by $0.20, revenue of $25.7M beats by $8.65M | N/A | |
| 2022-04-26 17:35 EST | News | Protagonist hits 52-week low as Street reacts to data for ulcerative colitis candidate | N/A | |
| 2022-04-26 01:38 EST | News | Protagonist falls on data from phase 2 study of PN-943 to treat ulcerative colitis | N/A | |
| 2022-04-15 02:54 EST | News | Protagonist down 22% after FDA plans to rescind Breakthrough Therapy designation for rusfertide | N/A | |
| 2022-03-29 08:38 EST | News | Asif Ali is the new finance chief at Protagonist Therapeutics | N/A | |
| 2022-02-28 17:25 EST | News | Protagonist GAAP EPS of -$0.77 beats by $0.02, revenue of $8.62M beats by $4.62M | N/A | |
| 2022-02-01 13:28 EST | News | Protagonist Is Still Being Undervalued Like There's Real Risk | N/A | |
| 2021-12-10 01:25 EST | News | Protagonist Therapeutics (PTGX) Investor Presentation - Slideshow | N/A | |
| 2021-12-02 23:48 EST | News | Protagonist chooses candidate to advance into phase 2 in collaboration with Janssen | N/A | |
| 2021-11-15 11:02 EST | News | Phase 2a data supports Protagonist genetic liver disease drug rusfertide | N/A | |
| 2021-10-12 11:34 EST | News | J.P. Morgan upgrades Protagonist to overweight following clinical hold removal | N/A | |
| 2021-10-11 16:22 EST | News | Protagonist gains nearly double after FDA removes clinical hold on rusfertide program | N/A | |
| 2021-10-11 16:21 EST | News | Protagonist price target raised at Northland following removal of clinical hold | N/A | |
| 2021-10-06 15:26 EST | News | PTGX is at high risk of performing badly | N/A | |
| 2021-09-30 21:08 EST | News | Protagonist Therapeutics: How To Buy The Dip | N/A | |
| 2021-09-28 00:11 EST | News | Warning: PTGX has been downgraded to Very Bearish | N/A | |
| 2021-09-25 08:13 EST | News | BELLUS Health, Akoya Biosciences lead weekly healthcare gainers; Protagonist trail | N/A | |
| 2021-09-22 04:02 EST | News | Protagonist loses more than half after FDA placed clinical hold on rusfertide studies | N/A | |
| 2021-09-22 04:01 EST | News | BELLUS Health, Akoya Biosciences lead weakly healthcare gainers; Protagonist trail | N/A | |
| 2021-09-22 04:00 EST | News | Protagonist extends slide as regulatory setback prompts downgrade at JP Morgan | N/A | |
| 2021-09-22 03:59 EST | News | Warning: PTGX has been downgraded to Very Bearish. | N/A | |
| 2021-08-10 10:13 EST | News | Protagonist Therapeutics resolves contract dispute with Zealand Pharma | N/A | |
| 2021-07-21 20:41 EST | News | Dosing underway in Protagonist Therapeutics' early-stage study of PN-232 | N/A | |
| 2021-07-21 20:32 EST | News | Protagonist wins FDA Breakthrough Therapy Designation for blood cancer therapy | N/A | |
| 2021-07-21 20:24 EST | News | Protagonist climbs on positive effect in mid-stage study for rusfertide in polycythemia vera | N/A | |
| 2021-07-21 20:23 EST | News | Biogen could reach over $600/share: Goldman Sachs, CRISPR upgraded on follow-up data; more in today’s analyst action | N/A | |
| 2021-07-21 20:22 EST | News | Protagonist Therapeutics slumps 7.5% on raising $100M via public offering | N/A | |
| 2021-07-21 20:22 EST | News | RAPT, SIOX, ACHL and PTGX among after-hours movers | N/A | |
| 2021-07-21 20:21 EST | News | Protagonist Therapeutics secures $115M capital via equity raise | N/A | |
| 2021-07-21 20:16 EST | News | Protagonist Therapeutics closes $132M capital raise | N/A | |
| 2021-05-05 01:39 EST | News | Protagonist EPS beats by $0.03, beats on revenue | N/A | |
| 2021-03-12 04:31 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-12 04:31 EST | Analyst Rating | The Analyst Target Price has increased from $35.4 to $37. | Buy | |
| 2021-03-11 12:47 EST | News | Protagonist Therapeutics, Inc. (PTGX) CEO Dinesh Patel on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-11 04:23 EST | Earnings Estimate | An EPS average of -$1.48 is estimated for the 2022 year. | Sell | |
About Protagonist Therapeutics, Inc (PTGX):
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. It is developing PTG-300, an injectable hepcidin mimetic that is in Phase II clinical trial for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PTG-200, an oral, interleukin-23 receptor specific antagonist peptide, which is in phase II clinical trial for the treatment of moderate-to-severe Crohn's disease; and PN-943, an oral, alpha-4-beta-7 specific integrin antagonist that is in Phase II clinical trial for treating inflammatory bowel disease (IBD). The company has a license and collaboration agreement with Janssen Biotech, Inc. for the development, manufacture, and commercialization of PTG-200 for the treatment of Crohn's disease and ulcerative colitis; and PN-235 and PN-232 oral interleukin-23 receptor antagonist candidates for IBD and non-IBD indications. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
General
- Name Protagonist Therapeutics, Inc
- Symbol PTGX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 79
- Fiscal Year EndDecember
- IPO Date2016-08-11
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.protagonist-inc.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 37.31
- Price/Book (Most Recent Quarter) 4.86
- Enterprise Value Revenue 37.04
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.97
- Next Year EPS Estimate -$2.12
- Next Quarter EPS Estimate -$0.54
- Profit Margin -231%
- Operating Margin -225%
- Return on Assets -17%
- Return on Equity -37%
- Revenue 28.63 million
- Earnings Per Share -$2.74
- Revenue Per Share $0.83
- Gross Profit 28.63 million
- Quarterly Earnings Growth 107.8%
View More
Highlights
- Market Capitalization 1.36 billion
- EBITDA -70271000
- Analyst Target Price $37
- Book Value Per Share $6.39
View More
Share Statistics
- Shares Outstanding 43.81 million
- Shares Float 27.88 million
- % Held by Insiders 161%
- % Held by Institutions 93.65%
- Shares Short 2.77 million
- Shares Short Prior Month 2.78 million
- Short Ratio 8.34
- Short % of Float 7%
- Short % of Shares Outstanding 6%
View More
Technicals
- Beta 1.55
- 52 Week High $31.58
- 52 Week Low $5.44
- 50 Day Moving Average 26.03
- 200 Day Moving Average 22.63
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Protagonist Therapeutics, Inc (PTGX) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Protagonist Therapeutics, Inc (PTGX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-10 | $5.65 million | -$0.48 | -$0.48 | -0.61% |
| 2020-09-30 | 2020-11-04 | $N/A | -$0.21 | -$0.61 | 65.71% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.59 | -$0.57 | -2.91% |
| 2020-03-31 | 2020-05-07 | $3.65 million | -$0.72 | -$0.69 | -4.05% |
| 2019-12-31 | 2020-03-10 | $2.72 million | -$0.63 | -$0.65 | 2.78% |
| 2019-09-30 | 2019-11-06 | $4.14 million | -$0.61 | -$0.77 | 20.26% |
| 2019-06-30 | 2019-08-07 | $-8189000 | -$1.18 | -$0.39 | -206.49% |
| 2019-03-31 | 2019-05-08 | $1.56 million | -$0.58 | -$0.56 | -4.5% |
| 2018-12-31 | 2019-03-12 | $2.35 million | -$0.57 | -$0.47 | -20.25% |
| 2018-09-30 | 2018-11-06 | $6.12 million | -$0.38 | -$0.37 | -1.79% |
| 2018-06-30 | 2018-08-07 | $11.67 million | -$0.41 | -$0.30 | -35.18% |
| 2018-03-31 | 2018-05-09 | $10.78 million | -$0.36 | -$0.24 | -50% |
| 2017-12-31 | 2018-03-07 | $11.28 million | -$0.15 | -$0.34 | 55.88% |
| 2017-09-30 | 2017-11-06 | $8.78 million | -$0.29 | -$0.81 | 63.98% |
| 2017-06-30 | 2017-08-08 | $N/A | -$0.89 | -$0.86 | -4.09% |
| 2017-03-31 | 2017-05-10 | $N/A | -$0.84 | -$0.67 | -26.32% |
| 2016-12-31 | 2017-03-07 | $N/A | -$0.67 | -$0.52 | -28.85% |
| 2016-09-30 | 2016-11-14 | $N/A | -$0.87 | -$0.64 | -35.94% |
| 2016-06-30 | 2016-07-11 | $N/A | -$40.89 | -$0.83 | -4826.51% |
Protagonist Therapeutics, Inc (PTGX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Protagonist Therapeutics, Inc (PTGX) Chart:
Protagonist Therapeutics, Inc (PTGX) News:
Below you will find a list of latest news for Protagonist Therapeutics, Inc (PTGX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Protagonist Therapeutics, Inc (PTGX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-04-17 | 20 | 0 | CALL | 0 | 0 | 174.15 | TRUE | 0 | 0 |
| 2025-04-17 | 22.5 | 17.4 | CALL | 0 | 50 | 252.21 | TRUE | 0 | 0 |
| 2025-04-17 | 25 | 18.63 | CALL | 0 | 50 | 156.45 | TRUE | 0 | 0 |
| 2025-04-17 | 30 | 16.9 | CALL | 0 | 2 | 117.94 | TRUE | 0 | 0 |
| 2025-04-17 | 35 | 21.36 | CALL | 0 | 17 | 95.67 | TRUE | 0 | 0 |
| 2025-04-17 | 40 | 5 | CALL | 5 | 53 | 79.45 | TRUE | 5 | 0 |
| 2025-04-17 | 45 | 1.45 | CALL | 36 | 3463 | 102.97 | FALSE | 1.45 | 0 |
| 2025-04-17 | 50 | 0.35 | CALL | 2 | 1937 | 93.52 | FALSE | 0 | 0 |
| 2025-04-17 | 55 | 0.1 | CALL | 0 | 683 | 126.18 | FALSE | 0 | 0 |
| 2025-04-17 | 60 | 0.15 | CALL | 0 | 1519 | 151.47 | FALSE | 0 | 0 |
| 2025-04-17 | 65 | 0.5 | CALL | 0 | 72 | 175.65 | FALSE | 0 | 0 |
| 2025-04-17 | 70 | 0.31 | CALL | 0 | 8 | 197.23 | FALSE | 0 | 0 |
| 2025-04-17 | 75 | 0 | CALL | 0 | 0 | 365.77 | FALSE | 0 | 0 |
| 2025-04-17 | 80 | 0 | CALL | 0 | 0 | 388.54 | FALSE | 0 | 0 |
| 2025-04-17 | 85 | 0 | CALL | 0 | 0 | 409.36 | FALSE | 0 | 0 |
| 2025-04-17 | 20 | 0 | PUT | 0 | 0 | 542.41 | FALSE | 0 | 0 |
| 2025-04-17 | 22.5 | 0.15 | PUT | 0 | 32 | 218.84 | FALSE | 0 | 0 |
| 2025-04-17 | 25 | 0.1 | PUT | 0 | 1009 | 154.95 | FALSE | 0 | 0 |
| 2025-04-17 | 30 | 1.97 | PUT | 0 | 15 | 263.72 | FALSE | 0 | 0 |
| 2025-04-17 | 35 | 0.25 | PUT | 0 | 672 | 102.18 | FALSE | 0 | 0 |
| 2025-04-17 | 40 | 1.35 | PUT | 27 | 1046 | 81.98 | FALSE | 0.65 | 0.93 |
| 2025-04-17 | 45 | 4.8 | PUT | 1068 | 2076 | 105.55 | TRUE | 1.9 | 0.66 |
| 2025-04-17 | 50 | 8 | PUT | 6 | 312 | 110.98 | TRUE | 8 | 0 |
| 2025-04-17 | 55 | 11.75 | PUT | 0 | 610 | 117.64 | TRUE | 0 | 0 |
| 2025-04-17 | 60 | 12.6 | PUT | 0 | 6 | 238.04 | TRUE | 0 | 0 |
| 2025-04-17 | 65 | 13.2 | PUT | 0 | 0 | 161.55 | TRUE | 0 | 0 |
| 2025-04-17 | 70 | 15.5 | PUT | 0 | 2 | 300.61 | TRUE | 0 | 0 |
| 2025-04-17 | 75 | 0 | PUT | 0 | 0 | 222.53 | TRUE | 0 | 0 |
| 2025-04-17 | 80 | 0 | PUT | 0 | 0 | 247.03 | TRUE | 0 | 0 |
| 2025-04-17 | 85 | 0 | PUT | 0 | 0 | 257.92 | TRUE | 0 | 0 |
| 2025-05-16 | 30 | 0 | CALL | 0 | 0 | 66.37 | TRUE | 0 | 0 |
| 2025-05-16 | 35 | 10.8 | CALL | 0 | 90 | 78.87 | TRUE | 0 | 0 |
| 2025-05-16 | 40 | 5.1 | CALL | 0 | 11 | 71.71 | TRUE | 0 | 0 |
| 2025-05-16 | 45 | 3.2 | CALL | 0 | 10 | 66.74 | FALSE | 0 | 0 |
| 2025-05-16 | 50 | 1.4 | CALL | 0 | 503 | 66.17 | FALSE | 0 | 0 |
| 2025-05-16 | 55 | 2 | CALL | 0 | 1000 | 78.13 | FALSE | 0 | 0 |
| 2025-05-16 | 60 | 0 | CALL | 0 | 0 | 102.56 | FALSE | 0 | 0 |
| 2025-05-16 | 65 | 0 | CALL | 0 | 0 | 118.03 | FALSE | 0 | 0 |
| 2025-05-16 | 70 | 0 | CALL | 0 | 0 | 165.14 | FALSE | 0 | 0 |
| 2025-05-16 | 75 | 0 | CALL | 0 | 0 | 177.4 | FALSE | 0 | 0 |
| 2025-05-16 | 80 | 0 | CALL | 0 | 0 | 188.5 | FALSE | 0 | 0 |
| 2025-05-16 | 30 | 0 | PUT | 0 | 0 | 91.6 | FALSE | 0 | 0 |
| 2025-05-16 | 35 | 0 | PUT | 0 | 0 | 97.68 | FALSE | 0 | 0 |
| 2025-05-16 | 40 | 1.1 | PUT | 0 | 14 | 68.11 | FALSE | 0 | 0 |
| 2025-05-16 | 45 | 2.44 | PUT | 0 | 28 | 68.66 | TRUE | 0 | 0 |
| 2025-05-16 | 50 | 5 | PUT | 0 | 56 | 72.14 | TRUE | 0 | 0 |
| 2025-05-16 | 55 | 0 | PUT | 0 | 0 | 68.14 | TRUE | 0 | 0 |
| 2025-05-16 | 60 | 0 | PUT | 0 | 0 | 78.39 | TRUE | 0 | 0 |
| 2025-05-16 | 65 | 0 | PUT | 0 | 0 | 71.79 | TRUE | 0 | 0 |
| 2025-05-16 | 70 | 0 | PUT | 0 | 0 | 96.3 | TRUE | 0 | 0 |
| 2025-05-16 | 75 | 0 | PUT | 0 | 0 | 115.42 | TRUE | 0 | 0 |
| 2025-05-16 | 80 | 0 | PUT | 0 | 0 | 115.5 | TRUE | 0 | 0 |
| 2025-07-18 | 20 | 33 | CALL | 0 | 20 | 71.48 | TRUE | 0 | 0 |
| 2025-07-18 | 22.5 | 15.44 | CALL | 0 | 80 | 71.03 | TRUE | 0 | 0 |
| 2025-07-18 | 25 | 15.99 | CALL | 0 | 80 | 68.98 | TRUE | 0 | 0 |
| 2025-07-18 | 30 | 27.6 | CALL | 0 | 20 | 55.88 | TRUE | 0 | 0 |
| 2025-07-18 | 35 | 25 | CALL | 0 | 10 | 56.61 | TRUE | 0 | 0 |
| 2025-07-18 | 40 | 20.32 | CALL | 0 | 32 | 57.81 | TRUE | 0 | 0 |
| 2025-07-18 | 45 | 12 | CALL | 0 | 61 | 55.83 | FALSE | 0 | 0 |
| 2025-07-18 | 50 | 2.15 | CALL | 1 | 73 | 53.84 | FALSE | 2.15 | 0 |
| 2025-07-18 | 55 | 5.8 | CALL | 0 | 16 | 56.48 | FALSE | 0 | 0 |
| 2025-07-18 | 60 | 1 | CALL | 0 | 1073 | 55.1 | FALSE | 0 | 0 |
| 2025-07-18 | 65 | 0.95 | CALL | 0 | 1341 | 57.32 | FALSE | 0 | 0 |
| 2025-07-18 | 70 | 3.6 | CALL | 0 | 6 | 63.49 | FALSE | 0 | 0 |
| 2025-07-18 | 75 | 0.34 | CALL | 0 | 4 | 84.16 | FALSE | 0 | 0 |
| 2025-07-18 | 80 | 0 | CALL | 0 | 0 | 90.87 | FALSE | 0 | 0 |
| 2025-07-18 | 85 | 0 | CALL | 0 | 0 | 96.55 | FALSE | 0 | 0 |
| 2025-07-18 | 20 | 0 | PUT | 0 | 0 | 123.45 | FALSE | 0 | 0 |
| 2025-07-18 | 22.5 | 1.25 | PUT | 0 | 3 | 107.32 | FALSE | 0 | 0 |
| 2025-07-18 | 25 | 1.65 | PUT | 0 | 1 | 89.44 | FALSE | 0 | 0 |
| 2025-07-18 | 30 | 1.5 | PUT | 0 | 259 | 65.97 | FALSE | 0 | 0 |
| 2025-07-18 | 35 | 2.4 | PUT | 701 | 20 | 65.14 | FALSE | 2.4 | 0 |
| 2025-07-18 | 40 | 2.65 | PUT | 0 | 33 | 66.94 | FALSE | 0 | 0 |
| 2025-07-18 | 45 | 4.2 | PUT | 0 | 821 | 57.98 | TRUE | 0 | 0 |
| 2025-07-18 | 50 | 5.5 | PUT | 0 | 22 | 58.88 | TRUE | 0 | 0 |
| 2025-07-18 | 55 | 8.5 | PUT | 0 | 25 | 58.28 | TRUE | 0 | 0 |
| 2025-07-18 | 60 | 13.2 | PUT | 0 | 10 | 63.75 | TRUE | 0 | 0 |
| 2025-07-18 | 65 | 22.51 | PUT | 0 | 1 | 65.36 | TRUE | 0 | 0 |
| 2025-07-18 | 70 | 22 | PUT | 0 | 5 | 68.97 | TRUE | 0 | 0 |
| 2025-07-18 | 75 | 0 | PUT | 0 | 0 | 81.49 | TRUE | 0 | 0 |
| 2025-07-18 | 80 | 33.3 | PUT | 0 | 0 | 78.6 | TRUE | 0 | 0 |
| 2025-07-18 | 85 | 0 | PUT | 0 | 0 | 92.73 | TRUE | 0 | 0 |
| 2025-10-17 | 20 | 16.5 | CALL | 0 | 44 | 68.96 | TRUE | 0 | 0 |
| 2025-10-17 | 22.5 | 31 | CALL | 0 | 1 | 68.55 | TRUE | 0 | 0 |
| 2025-10-17 | 25 | 0 | CALL | 0 | 0 | 66.78 | TRUE | 0 | 0 |
| 2025-10-17 | 30 | 0 | CALL | 0 | 0 | 64.74 | TRUE | 0 | 0 |
| 2025-10-17 | 35 | 0 | CALL | 0 | 0 | 63.71 | TRUE | 0 | 0 |
| 2025-10-17 | 40 | 10.4 | CALL | 0 | 1 | 60.92 | TRUE | 0 | 0 |
| 2025-10-17 | 45 | 12.9 | CALL | 0 | 3 | 59.1 | FALSE | 0 | 0 |
| 2025-10-17 | 50 | 5.4 | CALL | 0 | 9 | 65.93 | FALSE | 0 | 0 |
| 2025-10-17 | 55 | 4.6 | CALL | 0 | 22 | 66.56 | FALSE | 0 | 0 |
| 2025-10-17 | 60 | 3.3 | CALL | 0 | 20 | 61.38 | FALSE | 0 | 0 |
| 2025-10-17 | 65 | 7.2 | CALL | 0 | 7 | 59.55 | FALSE | 0 | 0 |
| 2025-10-17 | 70 | 1.6 | CALL | 0 | 3 | 57.12 | FALSE | 0 | 0 |
| 2025-10-17 | 75 | 2.35 | CALL | 0 | 2 | 65.86 | FALSE | 0 | 0 |
| 2025-10-17 | 80 | 0 | CALL | 0 | 0 | 68.49 | FALSE | 0 | 0 |
| 2025-10-17 | 85 | 3.35 | CALL | 0 | 1 | 74.47 | FALSE | 0 | 0 |
| 2025-10-17 | 20 | 0 | PUT | 0 | 0 | 110.87 | FALSE | 0 | 0 |
| 2025-10-17 | 22.5 | 0 | PUT | 0 | 0 | 77.62 | FALSE | 0 | 0 |
| 2025-10-17 | 25 | 0 | PUT | 0 | 0 | 71.64 | FALSE | 0 | 0 |
| 2025-10-17 | 30 | 5 | PUT | 0 | 44 | 72.79 | FALSE | 0 | 0 |
| 2025-10-17 | 35 | 1.65 | PUT | 0 | 2 | 65.33 | FALSE | 0 | 0 |
| 2025-10-17 | 40 | 4.5 | PUT | 0 | 19 | 61.02 | FALSE | 0 | 0 |
| 2025-10-17 | 45 | 5.4 | PUT | 0 | 15 | 66.81 | TRUE | 0 | 0 |
| 2025-10-17 | 50 | 5.9 | PUT | 0 | 30 | 59.39 | TRUE | 0 | 0 |
| 2025-10-17 | 55 | 10.6 | PUT | 0 | 104 | 59.94 | TRUE | 0 | 0 |
| 2025-10-17 | 60 | 13 | PUT | 0 | 2 | 57.26 | TRUE | 0 | 0 |
| 2025-10-17 | 65 | 0 | PUT | 0 | 0 | 58.67 | TRUE | 0 | 0 |
| 2025-10-17 | 70 | 0 | PUT | 0 | 0 | 62.25 | TRUE | 0 | 0 |
| 2025-10-17 | 75 | 0 | PUT | 0 | 0 | 62.97 | TRUE | 0 | 0 |
| 2025-10-17 | 80 | 0 | PUT | 0 | 0 | 68.03 | TRUE | 0 | 0 |
| 2025-10-17 | 85 | 27.4 | PUT | 0 | 0 | 72.74 | TRUE | 0 | 0 |
Latest PTGX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 13 | $7.08 |
| Jun 13, 2022 7:59 PM EST | 8 | $7.07 |
| Jun 13, 2022 7:59 PM EST | 1 | $7.07 |
| Jun 13, 2022 7:59 PM EST | 14 | $7.07 |
| Jun 13, 2022 7:59 PM EST | 34 | $7.09 |
Protagonist Therapeutics, Inc (PTGX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000083423720009556/0000834237-20-009556-index.htm |
| 2018-09-18 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1377121/000000000018029279/0000000000-18-029279-index.htm |
| 2019-11-21 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1377121/000000000019015720/0000000000-19-015720-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000031506619001298/0000315066-19-001298-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000031506620001141/0000315066-20-001141-index.htm |
| 2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000083423720008027/0000834237-20-008027-index.htm |
| 2020-06-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000083423720009556/0000834237-20-009556-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000090266419000928/0000902664-19-000928-index.htm |
| 2020-05-22 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000090266420002197/0000902664-20-002197-index.htm |
| 2018-08-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000092189518002281/0000921895-18-002281-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000092189519000465/0000921895-19-000465-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000092189520000521/0000921895-20-000521-index.htm |
| 2018-07-02 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000093041318002140/0000930413-18-002140-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000093041319000575/0000930413-19-000575-index.htm |
| 2018-08-07 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1377121/000104746918005447/0001047469-18-005447-index.htm |
| 2018-09-07 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1377121/000104746918006015/0001047469-18-006015-index.htm |
| 2018-09-26 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1377121/000104746918006444/0001047469-18-006444-index.htm |
| 2019-04-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1377121/000104746919002642/0001047469-19-002642-index.htm |
| 2019-10-31 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1377121/000104746919006014/0001047469-19-006014-index.htm |
| 2019-11-27 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1377121/000104746919006551/0001047469-19-006551-index.htm |
| 2020-04-16 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1377121/000104746920002368/0001047469-20-002368-index.htm |
| 2020-05-11 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1377121/000104746920002943/0001047469-20-002943-index.htm |
| 2020-05-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1377121/000104746920003025/0001047469-20-003025-index.htm |
| 2018-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465918049635/0001104659-18-049635-index.htm |
| 2018-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465918049963/0001104659-18-049963-index.htm |
| 2018-09-20 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1377121/000110465918057889/0001104659-18-057889-index.htm |
| 2018-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465918063178/0001104659-18-063178-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465918066340/0001104659-18-066340-index.htm |
| 2018-11-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465918070107/0001104659-18-070107-index.htm |
| 2018-12-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465918075322/0001104659-18-075322-index.htm |
| 2019-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465919014250/0001104659-19-014250-index.htm |
| 2019-03-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1377121/000110465919014317/0001104659-19-014317-index.htm |
| 2019-03-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465919017130/0001104659-19-017130-index.htm |
| 2019-04-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1377121/000110465919024116/0001104659-19-024116-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465919027659/0001104659-19-027659-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465919027662/0001104659-19-027662-index.htm |
| 2019-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465919029003/0001104659-19-029003-index.htm |
| 2019-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465919032445/0001104659-19-032445-index.htm |
| 2019-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465919035338/0001104659-19-035338-index.htm |
| 2019-06-17 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000110465919035942/0001104659-19-035942-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465919044426/0001104659-19-044426-index.htm |
| 2019-10-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465919058437/0001104659-19-058437-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465919060537/0001104659-19-060537-index.htm |
| 2019-11-20 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1377121/000110465919065981/0001104659-19-065981-index.htm |
| 2019-11-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465919068332/0001104659-19-068332-index.htm |
| 2019-12-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465919069217/0001104659-19-069217-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000110465920021728/0001104659-20-021728-index.htm |
| 2020-02-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465920024253/0001104659-20-024253-index.htm |
| 2020-03-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465920031381/0001104659-20-031381-index.htm |
| 2020-03-10 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1377121/000110465920031453/0001104659-20-031453-index.htm |
| 2020-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465920035420/0001104659-20-035420-index.htm |
| 2020-04-16 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1377121/000110465920047714/0001104659-20-047714-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465920058140/0001104659-20-058140-index.htm |
| 2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465920059922/0001104659-20-059922-index.htm |
| 2020-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465920067747/0001104659-20-067747-index.htm |
| 2020-06-08 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1377121/000110465920070830/0001104659-20-070830-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465920091424/0001104659-20-091424-index.htm |
| 2020-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465920094719/0001104659-20-094719-index.htm |
| 2020-09-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465920104437/0001104659-20-104437-index.htm |
| 2020-10-02 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465920111763/0001104659-20-111763-index.htm |
| 2020-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000110465920121408/0001104659-20-121408-index.htm |
| 2018-12-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000119312518345594/0001193125-18-345594-index.htm |
| 2019-01-24 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000119312519015661/0001193125-19-015661-index.htm |
| 2019-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000119312519028285/0001193125-19-028285-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000119312519040996/0001193125-19-040996-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000119312520038117/0001193125-20-038117-index.htm |
| 2018-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919118037316/0001209191-18-037316-index.htm |
| 2018-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919118037317/0001209191-18-037317-index.htm |
| 2018-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919118037318/0001209191-18-037318-index.htm |
| 2018-07-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919118042575/0001209191-18-042575-index.htm |
| 2018-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919118047543/0001209191-18-047543-index.htm |
| 2018-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919118047547/0001209191-18-047547-index.htm |
| 2018-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919118047548/0001209191-18-047548-index.htm |
| 2018-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919118047549/0001209191-18-047549-index.htm |
| 2019-01-09 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119003141/0001209191-19-003141-index.htm |
| 2019-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119003606/0001209191-19-003606-index.htm |
| 2019-01-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119003645/0001209191-19-003645-index.htm |
| 2019-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119003994/0001209191-19-003994-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119008675/0001209191-19-008675-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119008679/0001209191-19-008679-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119008690/0001209191-19-008690-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119015926/0001209191-19-015926-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119015927/0001209191-19-015927-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119015930/0001209191-19-015930-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119015935/0001209191-19-015935-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119015939/0001209191-19-015939-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119022776/0001209191-19-022776-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119022784/0001209191-19-022784-index.htm |
| 2019-05-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119030616/0001209191-19-030616-index.htm |
| 2019-06-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119034081/0001209191-19-034081-index.htm |
| 2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119034082/0001209191-19-034082-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119036195/0001209191-19-036195-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119036203/0001209191-19-036203-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119036204/0001209191-19-036204-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119036207/0001209191-19-036207-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119036211/0001209191-19-036211-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119036214/0001209191-19-036214-index.htm |
| 2019-08-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119045195/0001209191-19-045195-index.htm |
| 2019-08-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119045196/0001209191-19-045196-index.htm |
| 2019-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119058295/0001209191-19-058295-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119058799/0001209191-19-058799-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119058800/0001209191-19-058800-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119058839/0001209191-19-058839-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919119058853/0001209191-19-058853-index.htm |
| 2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120014088/0001209191-20-014088-index.htm |
| 2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120014090/0001209191-20-014090-index.htm |
| 2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120014092/0001209191-20-014092-index.htm |
| 2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120014097/0001209191-20-014097-index.htm |
| 2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120014100/0001209191-20-014100-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120018645/0001209191-20-018645-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120018752/0001209191-20-018752-index.htm |
| 2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120020714/0001209191-20-020714-index.htm |
| 2020-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120023949/0001209191-20-023949-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120026593/0001209191-20-026593-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120033016/0001209191-20-033016-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120033020/0001209191-20-033020-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120033022/0001209191-20-033022-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120033026/0001209191-20-033026-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120033031/0001209191-20-033031-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120033032/0001209191-20-033032-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120046427/0001209191-20-046427-index.htm |
| 2020-08-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120047233/0001209191-20-047233-index.htm |
| 2020-08-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1377121/000120919120047246/0001209191-20-047246-index.htm |
| 2018-08-20 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000121465918005609/0001214659-18-005609-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000121465919001113/0001214659-19-001113-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000121465920001392/0001214659-20-001392-index.htm |
| 2019-07-01 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000131924419000056/0001319244-19-000056-index.htm |
| 2019-12-16 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000149315219019237/0001493152-19-019237-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1377121/000149315220002364/0001493152-20-002364-index.htm |
| 2018-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1377121/000155837018006590/0001558370-18-006590-index.htm |
| 2018-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1377121/000155837018006639/0001558370-18-006639-index.htm |
| 2018-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1377121/000155837018008657/0001558370-18-008657-index.htm |
| 2019-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1377121/000155837019001853/0001558370-19-001853-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1377121/000155837019004481/0001558370-19-004481-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1377121/000155837019007515/0001558370-19-007515-index.htm |
| 2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1377121/000155837019010201/0001558370-19-010201-index.htm |
| 2020-03-10 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1377121/000155837020002334/0001558370-20-002334-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1377121/000155837020005785/0001558370-20-005785-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1377121/000155837020009681/0001558370-20-009681-index.htm |
| 2020-11-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1377121/000155837020012597/0001558370-20-012597-index.htm |
| 2018-09-21 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1377121/999999999518002437/9999999995-18-002437-index.htm |
| 2019-11-22 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1377121/999999999519002648/9999999995-19-002648-index.htm |
Protagonist Therapeutics, Inc (PTGX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Protagonist Therapeutics, Inc (PTGX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 161%Institutional Ownership: 9365%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-08-11 | CHAITAN PHD KHOSLA | Director | Sell | 2,499.00 | 17.19 | 42,952.06 | 0.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919120046427/0001209191-20-046427-index.htm |
| 2019-12-03 | Donald A. Kalkofen | Chief Financial Officer | Buy | 562.00 | 5.09 | 2,860.58 | 1,175.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119058800/0001209191-19-058800-index.htm |
| 2020-03-12 | HAROLD E SELICK | Director | Buy | 12,000.00 | 6.70 | 80,400.00 | 15,310.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919120018645/0001209191-20-018645-index.htm |
| 2019-02-28 | Suneel Gupta | EVP Clinical Operations | Buy | 7,500.00 | 17,500.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119015926/0001209191-19-015926-index.htm | ||
| 2019-02-06 | Richard S. Shames | Chief Medical Officer | Sell | 2,580.00 | 7.71 | 19,891.80 | 24,178.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119008675/0001209191-19-008675-index.htm |
| 2020-08-11 | CHAITAN PHD KHOSLA | Director | Buy | 2,499.00 | 1.89 | 4,723.11 | 2,499.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919120046427/0001209191-20-046427-index.htm |
| 2019-02-28 | Samuel R Saks | Chief Development Officer | Buy | 2,500.00 | 2,500.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119015930/0001209191-19-015930-index.htm | ||
| 2019-02-06 | Richard S. Shames | Chief Medical Officer | Sell | 198.00 | 8.15 | 1,613.70 | 26,758.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119008675/0001209191-19-008675-index.htm |
| 2018-08-15 | Richard S. Shames | Chief Medical Officer | Buy | 18,750.00 | 26,956.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919118047548/0001209191-18-047548-index.htm | ||
| 2018-08-15 | Thomas P. O'Neil | Chief Financial Officer | Buy | 21,100.00 | 30,560.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919118047549/0001209191-18-047549-index.htm | ||
| 2019-03-01 | Richard S. Shames | Chief Medical Officer | Sell | 657.00 | 8.03 | 5,275.71 | 32,021.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119015927/0001209191-19-015927-index.htm |
| 2019-02-28 | Richard S. Shames | Chief Medical Officer | Buy | 8,500.00 | 32,678.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119015927/0001209191-19-015927-index.htm | ||
| 2019-04-01 | HAROLD E SELICK | Director | Buy | 3,310.00 | 1.31 | 4,336.10 | 3,310.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119022784/0001209191-19-022784-index.htm |
| 2018-08-15 | DINESH V PH D PATEL | President and CEO | Buy | 82,050.00 | 345,829.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919118047547/0001209191-18-047547-index.htm | ||
| 2019-02-06 | DINESH V PH D PATEL | President and CEO | Sell | 10,132.00 | 7.71 | 78,117.72 | 357,264.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119008690/0001209191-19-008690-index.htm |
| 2019-02-06 | DINESH V PH D PATEL | President and CEO | Sell | 777.00 | 8.10 | 6,292.22 | 367,396.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119008690/0001209191-19-008690-index.htm |
| 2019-01-11 | DINESH V PH D PATEL | President and CEO | Buy | 22,344.00 | 1.16 | 25,919.04 | 368,173.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119003606/0001209191-19-003606-index.htm |
| 2019-02-06 | David Y Liu | Chief Scientific Officer | Sell | 3,821.00 | 7.74 | 29,561.55 | 37,007.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119008679/0001209191-19-008679-index.htm |
| 2019-08-06 | DINESH V PH D PATEL | President and CEO | Sell | 10,792.00 | 8.85 | 95,535.10 | 374,792.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119045195/0001209191-19-045195-index.htm |
| 2019-11-26 | DINESH V PH D PATEL | President and CEO | Buy | 4,000.00 | 1.16 | 4,640.00 | 379,824.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119058295/0001209191-19-058295-index.htm |
| 2019-03-01 | DINESH V PH D PATEL | President and CEO | Sell | 2,183.00 | 8.03 | 17,529.49 | 383,831.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119015935/0001209191-19-015935-index.htm |
| 2019-02-28 | DINESH V PH D PATEL | President and CEO | Buy | 28,750.00 | 386,014.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119015935/0001209191-19-015935-index.htm | ||
| 2019-12-03 | DINESH V PH D PATEL | President and CEO | Buy | 10,000.00 | 5.55 | 55,500.00 | 389,824.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119058799/0001209191-19-058799-index.htm |
| 2018-08-15 | David Y Liu | Chief Scientific Officer | Buy | 25,800.00 | 40,828.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919118047543/0001209191-18-047543-index.htm | ||
| 2019-12-03 | DINESH V PH D PATEL | President and CEO | Buy | 20,000.00 | 5.65 | 113,000.00 | 409,824.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119058799/0001209191-19-058799-index.htm |
| 2020-03-12 | DINESH V PH D PATEL | President and CEO | Buy | 18,344.00 | 1.16 | 21,279.04 | 429,990.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919120018752/0001209191-20-018752-index.htm |
| 2020-03-20 | DINESH V PH D PATEL | President and CEO | Buy | 10,000.00 | 1.89 | 18,900.00 | 439,990.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919120020714/0001209191-20-020714-index.htm |
| 2019-12-03 | Suneel Gupta | EVP Clinical Operations | Buy | 30,000.00 | 5.13 | 153,900.00 | 49,500.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119058839/0001209191-19-058839-index.htm |
| 2019-08-06 | David Y Liu | Chief Scientific Officer | Sell | 3,395.00 | 8.85 | 30,044.05 | 49,802.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119045196/0001209191-19-045196-index.htm |
| 2019-03-01 | David Y Liu | Chief Scientific Officer | Sell | 810.00 | 8.03 | 6,504.30 | 51,197.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119015939/0001209191-19-015939-index.htm |
| 2019-02-28 | David Y Liu | Chief Scientific Officer | Buy | 15,000.00 | 52,007.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119015939/0001209191-19-015939-index.htm | ||
| 2019-12-03 | Donald A. Kalkofen | Chief Financial Officer | Buy | 613.00 | 5.10 | 3,126.30 | 613.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119058800/0001209191-19-058800-index.htm |
| 2019-12-03 | Bryan Giraudo | Director | Buy | 8,000.00 | 5.70 | 45,620.00 | 8,000.00 | https://www.sec.gov/Archives/edgar/data/1377121/000120919119058853/0001209191-19-058853-index.htm |